Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.

@article{Yothers2011OutcomesAB,
  title={Outcomes among black patients with stage II and III colon cancer receiving chemotherapy: an analysis of ACCENT adjuvant trials.},
  author={Greg Yothers and Daniel J. Sargent and Norman Wolmark and Richard M. Goldberg and Michael J. O'Connell and Jacqueline Benedetti and Leonard Saltz and James J. Dignam and Arthur William Blackstock},
  journal={Journal of the National Cancer Institute},
  year={2011},
  volume={103 20},
  pages={1498-506}
}
BACKGROUND Among patients with resected colon cancer, black patients have worse survival than whites. We investigated whether disparities in survival and related endpoints would persist when patients were treated with identical therapies in controlled clinical trials. METHODS We assessed 14,611 patients (1218 black and 13,393 white) who received standardized adjuvant treatment in 12 randomized controlled clinical trials conducted in North America for resected stage II and stage III colon… CONTINUE READING